Related references
Note: Only part of the references are listed.Impact of pre-existing drug resistance on risk of virological failure in South Africa
Jonathan Z. Li et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
RNA and DNA Sanger sequencing versus next-generation sequencing for HIV-1 drug resistance testing in treatment-naive patients
E. K. Alidjinou et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial
Rami Kantor et al.
CLINICAL INFECTIOUS DISEASES (2015)
Clinical Implications of HIV-1 Minority Variants
Jonathan Z. Li et al.
CLINICAL INFECTIOUS DISEASES (2013)
A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers
Michael A. Quail et al.
BMC GENOMICS (2012)
Low-Frequency HIV-1 Drug Resistance Mutations and Risk of NNRTI-Based Antiretroviral Treatment Failure A Systematic Review and Pooled Analysis
Jonathan Z. Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Minority Variants of Drug-Resistant HIV
Sara Gianella et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Share Paper
